Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium ScaffoldBusiness Wire · 2 days ago
Teleflex Announces Third Quarter 2026 Earnings Conference Call InformationBusiness Wire · 2 days ago
Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium ScaffoldBusiness Wire · Oct 12, 2026
TFX or SONVY: Which Is the Better Value Stock Right Now?Zacks Investment Research · Oct 6, 2026
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?Zacks Investment Research · Oct 6, 2026
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ TechnologyBusiness Wire · Sep 29, 2026Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | $1.28 | $1.76 | Beat |
| May 7, 2026 | $1.21 | $1.39 | Beat |
| Feb 26, 2026 | $3.73 | $1.93 | Miss |
| Nov 6, 2025 | $3.38 | $3.67 | Beat |
| Jul 31, 2025 | $3.36 | $3.73 | Beat |
| May 1, 2025 | $2.88 | $2.91 | Beat |